GSK Investigational Site

Bornx, New York 10467

0 studies enrolling now · 1 studies all time

What they study most

Cancer

Studies at this site

• Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias — Completed